Mark Symbiosis Impex Private Limited - Company Profile

It is a trading private limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Mark Symbiosis Impex Private Limited

Mark Symbiosis Impex Private Limited, a struck off private limited company, was established on 26 May 2011 in Mumbai, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909MH2011PTC217953. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Amit Narhari Khedekar (Director), Umakant Narahari Khedekar (Director), Rajan Suresh Kambli (Director). Past directors included Surekha Kumar. It is based at New Liberty C.H.S. Ltd., B-18, Sankalp, 4Th Liberty Cross Lane, Malad (West),, Mumbai, Maharashtra, 400064.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2011PTC217953

  • Registration Number

    217953

  • Incorporation Date

    26 May 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 9 Months
Company report

Mark Symbiosis Impex Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mark Symbiosis Impex Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mark Symbiosis Impex Private Limited?
Current Directors
Name Designation Appointment Date Status
Amit Narhari Khedekar Director 26 May 2011 Current
Umakant Narahari Khedekar Director 26 May 2011 Current
Rajan Suresh Kambli Director 26 May 2011 Current
Manisha Rajan Kambli Director 26 May 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Aug 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mark Symbiosis Impex.

Enhance accessibility to Mark Symbiosis Impex's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Mark Symbiosis Impex revenue growth over time
Mark Symbiosis Impex profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mark Symbiosis Impex?

Unlock access to Mark Symbiosis Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Mark Symbiosis Impex?

Unlock and access historical data on people associated with Mark Symbiosis Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mark Symbiosis Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mark Symbiosis Impex's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mark Symbiosis Impex
Recent Activity within the Organization
  • Director Appointment

    Amit Narhari Khedekar was appointed as a Director was appointed as a Director on 26 May 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.

  • Director Appointment

    Umakant Narahari Khedekar was appointed as a Director was appointed as a Director on 26 May 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Rajan Suresh Kambli was appointed as a Director was appointed as a Director on 26 May 2011 & has been associated with this company since 14 years 9 months . was completed.

  • Director Appointment

    Manisha Rajan Kambli was appointed as a Director was appointed as a Director on 26 May 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.

  • Company Incorporation

    Mark Symbiosis Impex Private Limited was registered on 26 May 2011 with Roc Mumbai & aged 14 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mark Symbiosis Impex Private Limited?

The CIN of Mark Symbiosis Impex Private Limited is U51909MH2011PTC217953.

Where is Mark Symbiosis Impex Private Limited headquartered?

Mark Symbiosis Impex Private Limited is headquartered at New Liberty C.H.S. Ltd., B-18, Sankalp, 4Th Liberty Cross Lane, Malad (West),, Mumbai, Maharashtra, 400064.

When was Mark Symbiosis Impex Private Limited incorporated?

Mark Symbiosis Impex Private Limited was incorporated on 26 May 2011.

Who are the current directors of Mark Symbiosis Impex Private Limited?

The current directors of Mark Symbiosis Impex Private Limited are

What is the primary industry of Mark Symbiosis Impex Private Limited?

The primary industry of Mark Symbiosis Impex Private Limited is Trading.

Is Mark Symbiosis Impex Private Limited a listed company?

Mark Symbiosis Impex Private Limited is unlisted.

What is the capital structure of Mark Symbiosis Impex Private Limited?

The authorized capital of Mark Symbiosis Impex Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available